Redox-Mediated Anticancer Activity of Anti-Parasitic Drug Fenbendazole in Triple-Negative Breast Cancer Cells

Scientists investigated the possibility of selective redox-mediated treatment of TNBC cells by fenbendazole without affecting the viability and redox status of normal breast epithelial cells.